Email this article Content of the antigenic determinants CD16, CD 25,CD95, and HLA-DR in the induced sputum of patientswith bronchial asthma and chronic obstructive bronchitis
- Authors: Nevzorova VA1, Konovalova Y.N1, Pazych SA1, Kostyushko AV1
-
Affiliations:
- Владивостокский государственный медицинский университет
- Issue: Vol 78, No 11 (2003)
- Pages: 61-63
- Section: Editorial
- URL: https://bakhtiniada.ru/0040-3660/article/view/29709
- ID: 29709
Cite item
Full Text
Abstract
Aim. To examine the content of CD16, CD 25, CD95, and HLA-DR antigenic determinants in induced sputum (IS) of patients with bronchial asthma (BA) and chronic obstructive bronchitis (COB).
Materials and methods. The study enrolled 36 patients with BA and 15 with COB whose age was 21
to 58 years. The cellular precipitate of IS served as a material for the study. The studied receptors
were determined by immunofluorescence using the "Clonospectrum " monoclonal antibodies.
Results. There was an increase in the content of CD16, CD25, HLA-DR, CD95 whose expression was
decreased when glucocorticosteroids were used. At remission of asthma, the level of these receptors approximated that in the control group. On an exacerbation of COB, the content of these markers was
significantly less than that in the controls and the use of antibacterial agents and methylxanthines led
to its rise. At remission of COB, CD 16 and CD25 cells were not recorded.
Conclusion. The levels of membrane markers in IM of patients with BA and COB depend on the period of the disease and used therapy.
Materials and methods. The study enrolled 36 patients with BA and 15 with COB whose age was 21
to 58 years. The cellular precipitate of IS served as a material for the study. The studied receptors
were determined by immunofluorescence using the "Clonospectrum " monoclonal antibodies.
Results. There was an increase in the content of CD16, CD25, HLA-DR, CD95 whose expression was
decreased when glucocorticosteroids were used. At remission of asthma, the level of these receptors approximated that in the control group. On an exacerbation of COB, the content of these markers was
significantly less than that in the controls and the use of antibacterial agents and methylxanthines led
to its rise. At remission of COB, CD 16 and CD25 cells were not recorded.
Conclusion. The levels of membrane markers in IM of patients with BA and COB depend on the period of the disease and used therapy.
Keywords
About the authors
V A Nevzorova
Владивостокский государственный медицинский университетВладивостокский государственный медицинский университет
Ye N Konovalova
Владивостокский государственный медицинский университетВладивостокский государственный медицинский университет
S A Pazych
Владивостокский государственный медицинский университетВладивостокский государственный медицинский университет
A V Kostyushko
Владивостокский государственный медицинский университетВладивостокский государственный медицинский университет
References
- Ярилин А. А. Контактные межклеточные взаимодействия при иммунном ответе. Иммунология 1999; 1-2: 37-46.
- Ярилин А. А. Апоптоз: природа феномена и его роль в целостном организме. Пат. физиол. 1998; 8: 38-48.
- Ярилин А. А. Апоптоз и его место в иммунных процессах. Иммунология 1996; 6: 10-23.
- Бронхиальная астма. Глобальная стратегия. Современный доклад НИЗ (США) и ВОЗ (1993). Пульмонология 1996; Прил.: 4-9.
- Чучалин А. Г. Хронические обструктивные болезни легких. М.: ЗАО "Изд-во БИНОМ"; 1999.
- Jaw-Ji Tsai, Ma J. K., Ting-Fang Wang Int. Arch. Allergy Appl. Immunol. 1995; 108: 183-188.
- Norak I. Clin. Immunol. Immunopathol. 1995; 76 (3): 172- 173.
- Metis M., Siena L., Pace E. et al. Fluticasone propionate (FP) induces apoptosis on IL-2 stimulated peripheral blood T-lymphocytes (PBT) isolated from normal and mild-moderate asthmatic patients. Eur. Respir. J. 1999; 14 (30): 67s.
- Потапнев M. IT., Печковский Д. В. Молекулярные и клеточные механизмы иммунопатологии при бронхиальной астме. Пульмонология 1997; 3: 75-79.
- Медуницын Н. В. Цитокины и аллергия, опосредованнаяIgE. Иммунология 1993; 5: 11-13.
- Feduc R. R., Adam A., Looney R. J. Clin. Immunol. Immunopathol. 1996; (2): 101-113.
- Казначеев К. С. Механизмы развития цитокининдуцированного апоптоза. Гематол. и трансфузиол. 1999; 44 (1): 40-43.
- Matsumoto К., Schleimer R. P., Saito H. et al. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995; 86: 1437-1443.
- Hebestreit H., Yousefi S., Balatti I. et al. Expression and fuction of the Fas receptor on human blood and tissue eosinophils.Eur. J. Immunol. 1996; 26: 1775-1780.
- Druilhe A., Wallaert В., Tsicopoulos A. et al. Apoptosis, proliferation and expression of BCL-2, Fas and Fas-ligand in bronchial biopsies from asthmatics. Am. J. Respir. Cell. Mol. Biol.1998; 19 (5): 747-757.
- Новиков Д. К., Мельникова Л. А. Иммунология 1993;
- Chitnis D., Diskerson C, Munster A. M., Winchurch R. A. Arch. Surg. 1996; 131: 24-30.
- Pin I., Gibson P. G., Kolendowicz R. et al. Use of induced turn from patients with chronic obstructive pulmonale disease or asthma. Am. J. Respir. Crit. Care Med. 1992; 147: 25-29.
Supplementary files
